Quantcast

Latest Apnea-hypopnea index Stories

2011-06-14 06:40:01

(Ivanhoe Newswire) "“ About 1 in 15 Americans have sleep apnea, and according to this study sleep apnea is associated with an increased risk of adverse pregnancy outcomes. Women with severe sleep apnea have the highest incidence of adverse pregnancy outcomes. This increased prevalence was primarily driven by a higher incidence of gestational diabetes and early preterm birth. "Our findings suggest that moderate to severe sleep-disordered breathing may be associated with adverse pregnancy...

2011-06-13 14:44:55

Pregnant women with severe sleep apnea may have an increased risk of gestational diabetes and early preterm birth Sleep apnea is associated with an increased risk of adverse pregnancy outcomes, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS). Results show that women with severe sleep apnea had the highest incidence of adverse pregnancy outcomes....

2011-05-16 16:27:34

Researchers have demonstrated the effectiveness of a novel treatment that stimulates the nerve that controls the diaphragm to normalize the breathing of patients who suffer from both heart failure and central sleep apnea. "Many heart failure patients suffer from central sleep apnea, which a number of studies have shown increases mortality in these patients," said Shahrokh Javaheri, MD, professor emeritus of medicine at the University of Cincinnati and medical director of Sleepcare Diagnostics...

2011-01-17 22:42:57

Performing polysomnography (sleep study) prior to pediatric adenotonsillectomy (surgical removal of the tonsils and adenoids) may help identify children at a higher risk of developing postoperative respiratory complications, according to a report in the January issue of Archives of Otolaryngology - Head Neck Surgery, one of the JAMA/Archives journals. "Pediatric adenotonsillectomy is a safe outpatient procedure; however, there is a subset of patients who do not meet the criteria for...

2010-06-08 06:00:00

MOUNTAIN VIEW, Calif., June 8 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data from a previously reported phase 2 study evaluating the safety and efficacy of the investigational drug Qnexa® for the treatment of obstructive sleep apnea (OSA) were presented at SLEEP 2010, the 24th Annual Meeting of the Associated Professional Sleep Societies (APSS). Data from the study entitled, "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group...

2010-06-06 07:37:37

According to new research that received the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, the ratio between tongue volume and bony enclosure size in patients with obstructive sleep apnea (OSA) may help dentists calculate oral appliance treatment success. Although mandibular advancement splints (MAS) have been shown to be a safe and effective treatment for OSA, predicting efficacy in individual patients is...

2010-06-06 07:33:50

According to new research that was presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, nasendoscopy may help dentists predict oral appliance therapy success in sleep apnea patients. Nasendoscopy involves a flexible endoscope being inserted through the nasal cavity. The tip of the scope is placed at the level of the velopharynx and oro-/hypopharynx. OAT has been shown to be a safe and effective treatment for patients with obstructive...

2010-01-07 06:00:00

MOUNTAIN VIEW, Calif., Jan. 7 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication. The study announced today demonstrated statistically...

2010-01-06 15:26:00

MOUNTAIN VIEW, Calif., Jan. 6 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) plans to announce the results from a phase 2 study evaluating the safety and efficacy of Qnexa, for the treatment of obstructive sleep apnea (OSA), on January 7th prior to market open. The announcement will be followed by a webcast and conference call at 8:30 a.m. Eastern time. Conference Call Information Domestic callers: 1- 888-806-6202 International callers: 1- 913-312-6680 Webcast information:...

2009-06-15 10:50:00

This study is the first to examine the relationship between obstructive sleep apnea and type 2 diabetes in a predominantly African-American and Hispanic populationA multi-ethnic study in the June 15 issue of the Journal of Clinical Sleep Medicine reports that there is a statistically significant relationship between obstructive sleep apnea (OSA) episodes occurring during rapid eye movement (REM) sleep and type 2 diabetes.Results indicate that the adjusted odds ratio for type 2 diabetes was...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related